After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
As a NASDAQ listed company, SRPT falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Sarepta Therapeutics Inc is $12.14B. A total of 0.86 million shares were traded on the day, compared to an average of 967.53K shares.
In the most recent transaction, Estepan Ian Michael sold 5,985 shares of SRPT for 137.36 per share on Aug 30 ’24. After the transaction, the Chief Financial Officer now owns 33,946 company shares. In a previous transaction on Aug 30 ’24, Estepan Ian Michael bought 5,985 shares at 137.37 per share.
Among the insiders who bought shares, Chambers Michael Andrew acquired of 37,038 shares on Aug 16 ’24 at a per-share price of $133.80. This resulted in the Director holding 284,034 shares of SRPT after the transaction. In another insider transaction, Brown Ryan Edward sold 38,957 shares at $161.61 per share on Jun 25 ’24. Company shares held by the EVP, General Counsel now total 17,129.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, SRPT has a high of $173.25 and a low of $55.25.
As of this writing, SRPT has an earnings estimate of -$0.15 per share for the current quarter. EPS was calculated based on a consensus of 13.0 estimates, with a high estimate of $0.7 per share and a lower estimate of -$0.81. The company reported an EPS of -$0.46 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. SRPT’s latest balance sheet shows that the firm has $2.12B in Cash & Short Term Investments as of fiscal 2021. There were $1.15B in debt and $452.73M in liabilities at the time. Its Book Value Per Share was $11.30, while its Total Shareholder’s Equity was $928.01M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SRPT is Buy with a score of 4.65.
